Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
AI - search results
If you're not happy with the results, please do another search
Heart failure drug may treat COVID-19 long-hauler symptom
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
70% of available COVID vaccines in 2021 have been pre-ordered
Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.
How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.
Covax will protect millions of Pakistanis against COVID-19
The global vaccine facility Covax will help Pakistan’s vaccination programme protect millions of Pakistanis against COVID-19.
Scientists are creating AI that can detect “anger or fear” in a public area
Korean scientists are creating an AI called 5G-I-VEmoSYS, which can read human emotions via wireless signals and body movement.
Scientists explain why plant diversity is crucial for bee conservation
Bumble bees and honey bees both depend on the same flower species in UK summers, which means that plant diversity is crucial to the survival of both species.
Rick Brar – Brains Bioceutical Corp.
Leading the helm at Brains Bioceutical, Rick is following his knowledge of the cannabis space into Europe.
Unpaid carers will have access to free PPE through national scheme
Unpaid carers will now benefit from free Personal Protective Equipment (PPE) through a new national scheme, the UK government has announced.
Paul Frainer – Institute of Economic Development (IED)
Paul Frainer is an experienced economic development, strategic urban and regional planning professional and board-level non-executive director.
Sustainable technology in the age of a pandemic
Lecturer and Interdisciplinary Researcher Chad Manian examines the progress of sustainable IT in the age of the COVID-19 pandemic, and discusses digital transformation as a means of crisis response.
How has the pandemic changed the insolvency landscape of retail and hospitality
Edward Wade, Content Author and Technical SEO at Wilson Field, explores how the coronavirus pandemic has changed the insolvency landscape of the retail and hospitality sector.
Dr Hatam H. Guliyev – Azerbaijan National Academy of Sciences
Hatam H. Guliyev and Rashid J. Javanshir discuss a fascinating aspect of geophysical research that concerns the Earth’s non-linear properties.
Dr Rashid J. Javanshir – Azerbaijan National Academy of Sciences
Dr Rashid Javanshir is a Corresponding member of the Azerbaijan National Academy of Sciences (NAS), who was one of the firsts in the former Soviet Union to establish cooperation with western geoscientists.
COVID-19 and coevolving informatics: Defence logic from meiosis to AI
Chris Girard, Associate Professor at Florida International University, explores COVID-19 and coevolving informatics, including comment on defence logic from meiosis to AI.
The app going up against centuries of education inequality
Nishat spoke to Tania Rosas who launched O-lab, the app created to fight education inequality for Indigenous students.
Scientists invent AI that creates COVID vaccine candidates within seconds
Scientists usually take months to analyse potential mutations of the virus, but this new AI can create COVID vaccine candidates within seconds.
What is the connection between pain and memory?
Researchers are investigating how everyday pain impacts memory - specifically, how do these daily experiences impact the way we think?
Data finds 300mg of coffee can solve short term cognitive impairment
Professor Renata Riha, at the Edinburgh Department of Sleep Medicine, released new data about how coffee can balance short term cognitive impairment - as experienced by sleep deprived people, or shift pattern workers.
Sputnik V vaccine is 91.6% effective against COVID
Interim data from Phase 3 clinical trials show that Russia's Sputnik V vaccine is capable of a 91.6% efficacy against COVID-19.
